Test and treat your UTI at home
The future of UTI diagnostics is here. Get precision testing and treatment with the BIOTIA-ID Urine Test.
Say goodbye to UTI.
Who is this test for?
Are you tired of constant urinary tract infections (UTIs), multiple doctor visits for treatments that don't work, and ultimately no answers? Are you at higher risk of UTIs or complications from UTIs? The BIOTIA-ID Urine Test may be for you.
Patients with recurrent and/or complicated UTIs have been ignored by the healthcare system for too long. That is why Biotia has engaged with leading clinicians and researchers in UTI care and infectious disease diagnostics to develop a full service, test-to-treat model of care. With a scientifically rigorous test and a team of providers specifically trained to help patients with recurrent and/or complicated UTI, you can trust Biotia to provide both the answers and treatment you need.
Put an end to the cycle.
Order the BIOTIA-ID Urine Test today.
The BIOTIA-ID Urine Test is for patients who have a recurrent, complicated, or culture-negative UTI.
- Recurrent UTI: having two or more symptomatic UTIs within a six month period, or three or more symptomatic UTIs within a year.
- Complicated UTI: a UTI in a patient who has certain risk factors, such as pregnancy, immunocompromised status, advanced age, catheterization, structural/functional abnormalities of the urogenital tract, and others.
- Culture-Negative UTI: urine culture is the first-line test for UTIs, however, it misses as many as 1/3 of cases. Not all bacteria and fungi grow in urine culture. If you received a negative urine culture result but still have symptoms of a UTI, you may benefit from the BIOTIA-ID Urine Test.
How is our test different?
- Uses cutting-edge technology, including next-generation sequencing and artificial intelligence
- Identifies all pathogen DNA in a urine sample rather than trying to grow organisms
- Detects pathogens often or entirely missed by traditional urine culture testing
- Helps your clinician decide the best course of treatment from a single test, collected at-home
- Developed with recurrent and complicated UTI patients in mind
How does it work?
We have worked closely with our telehealth partner to streamline the process for UTI testing and treatment. Simply purchase the test, set up your account on the Biotia Portal, collect and send your sample, and receive precise and personalized follow-up care and treatment.
Order Test + Create Account
Purchase the BIOTIA-ID Urine Test. Create your account and complete the eligibility form in the "Complete Order" tab. A provider will confirm your eligibility and a test kit will be shipped to your address.
Collect Sample At-Home
Collect your urine sample according to the instructions in the comfort and privacy of your home. Return the sample to the Biotia Laboratory via the prepaid, overnight shipping envelope contained within the kit.
Review Results
Results will be provided approximately 72 hours after we receive your sample. A report detailing which pathogens were detected will be made available on the Biotia Portal and sent to the provider assigned to you.
Optimized Treatment
Your provider will review and discuss your results with you, ensuring any questions you may have are answered. Your provider will provide optimized treatment recommendations, with any prescriptions made sent to your local pharmacy.
Who is our telehealth partner?
We have partnered with Clinova.Solutions to bring you UTI care you can trust. Clinova.Solutions is a leading telehealth group with a strong track record of bringing cutting-edge medical innovations directly to patients.
Contact Information:
Email: info@clinova.solutions
Text or Call: 210-972-2990
Dr. Jasmine Bonder
Dr. Jasmine Bonder, DNP, MSN, ACNP-BC, RN, is the Founder and CEO of Clinova.Solutions, a nationwide platform dedicated to expanding patient access to care through innovative asynchronous telemedicine services. She is a board-certified critical care nurse practitioner with over 10 years of experience managing high-acuity, complex medical cases across diverse clinical settings. With a strong background in urological care, she applies her expertise to deliver safe, effective, and personalized treatment strategies that help patients achieve the best possible outcomes.
Dr. Adam Bonder
Dr. Adam Bonder, MD, MBA, is the Medical Director of Clinova.Solutions, where he leads nationwide telemedicine initiatives designed to make high-quality care more accessible, convenient, and patient-centered through innovative asynchronous solutions. A board-certified emergency physician with over 15 years of frontline experience in acute and critical care, he brings expertise in advanced disease management and preventive health, particularly for patients facing recurrent or complex urinary tract infections. Committed to patient success, he champions accessible, high-quality care that improves outcomes across diverse populations.
A trusted model of care
The BIOTIA-ID Urine Test is backed by extensive clinical validation, meets strict performance and regulatory requirements, and was designed with recurrent UTI patients in mind.
Backed by Science
The BIOTIA-ID Urine Test has been rigorously validated on real patient specimens. As a laboratory-developed test (LDT), it has met strict performance requirements across all 50 U.S. states.
CLIA/CLEP-Certified Laboratory
Specimens are processed in our CLIA/CLEP-certified laboratory based in New York State and are tested by our highly-trained laboratory personnel. We do not send samples to third-party laboratories.
HIPAA Compliant Patient Portal
The Biotia Portal meets the strict requirements as set forth by the Health Insurance Portability and Accountability Act (HIPAA), ensuring your personal health information is securely managed.
Accountable to Patients
Live UTI Free, a leading patient advocacy group for recurrent UTI patients, has collaborated with Biotia to improve patient education regarding advanced diagnostic tests for UTI, such as the BIOTIA-ID Urine Test. Click the badge to learn more.
Institutional partners
"This cutting-edge technology allows for more precise and timely identification of atypical urogenital pathogens that often evade standard testing methods. By bridging this diagnostic gap, NGS technology may become an invaluable tool in tailoring targeted and effective treatment plans, ultimately elevating the standard of care for our most vulnerable patients suffering from complicated and recurrent UTI."
Vice Chair, Department of Medicine
Director, Division of Infectious Diseases
SUNY Downstate Health Sciences University,
Kings County Hospital Center
Want to test in-person?
The BIOTIA-ID Urine Test is the first-of-its-kind to be approved across all 50 U.S. states for use on urine samples. A growing number of clinicians are beginning to offer this advanced testing.
Use our map to find a provider that can order the BIOTIA-ID Urine Test for you during an in-person visit.